ReGen's Menaflex taken off the shelf in US as FDA rescinds clearance
This article was originally published in Clinica
Executive Summary
The US FDA has officially retracted its clearance of ReGen Biologics' Menaflex meniscus implant, forcing the firm to remove it from sale in the US.